| Company/Division name | Continuus Pharmaceuticals |
| Parent company | Continuus Pharmaceuticals |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| What product(s) and/or service(s) were outsourced domestically? | Manufacturing |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2021 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 85 |
| City reshored to: | Woburn |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | pharmaceutical |
| What domestic positive factors made reshoring more attractive? | Government Incentives, U.S. Department of Defense |
| Government Incentive dollar amount: | $70 million |
